Urotronic Inc.
Clinical trials sponsored by Urotronic Inc., explained in plain language.
-
New balloon treatment for urethral stricture under scrutiny for sperm safety
Disease control Recruiting nowThis study tests a special balloon coated with the drug paclitaxel, called Optilume, used to open narrowed areas in the urethra. Researchers want to see if it affects semen quality in men aged 22 to 65. The trial will measure changes in sperm concentration over 3 to 6 months in 3…
Phase: PHASE4 • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New balloon could open blocked ureters without surgery
Disease control Recruiting nowThis study tests a special balloon coated with the drug paclitaxel to treat narrowed sections of the ureter (the tube from kidney to bladder). The balloon is inflated to widen the stricture and release the drug to help keep it open. Researchers will check if the treatment is safe…
Phase: NA • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New balloon catheter aims to relieve prostate troubles
Symptom relief Recruiting nowThis study tests the Optilume BPH Catheter System, a device with a drug-coated balloon that opens the prostate to improve urine flow. About 92 men aged 50 and older with moderate to severe symptoms will be treated. Researchers will check if symptoms improve and track any serious …
Phase: NA • Sponsor: Urotronic Inc. • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC